Cancer screening & liquid biopsy based on EVs and exosomes
WE ARE A DISTRIBUTING PARTNER OF exosomics
Exosomics offers a wide range of proprietary solutions for cancer screening and liquid biopsy, suitable for research use and clinical diagnostics. Exosomics’ mission is to develop and commercialize a new generation of tests for cancer screening and liquid biopsy, based on analysis of circulating extracellular vesicles and exosomes. Exosomics envisions a world in which a simple blood draw will be sufficient for early diagnosis, easier monitoring and ultimately better patient outcomes.
EARLY – RELEVANT – NON-INVASIVE – AFFORDABLE
ExoRef are exosomes containing cancer relevant mutations at a verified allelic frequency in an anhydrous format. ExoRef standards allow the standardization of pre-analytical and analytical procedures involving the analysis of exosome content
Customized solutions for Research and Development: Isolation- Extraction – Detection
- Exosomics’ technology based on tumor-derived Exosomes and Tumor Hallmarks
Feel free to order now via our contact form to see how our products work for you!